IDH3A and glioblastoma: Aberrant expression of the α subunit of NAD-IDH (IDH3α) is found in glioblastoma and bipolar disorder patients, and elevated expression can promote progression of glioblastoma and other malignant tumors through regulation of one-carbon metabolism or HIF-1–mediated metabolic reprogramming and angiogenesis (10, –, 13).